Psychosurgery Promoted by NYT: Here We Go, Again
"Only 3 patients were in remission without adverse effects at long-term follow-up."
"Only 3 patients were in remission without adverse effects at long-term follow-up."
The pharmaceutical industry’s latest antidepression drug marketing campaign is being launched with collaboration of the National Institute of Mental Health (NIMH) “Real Men, Real Depression campaign http://menanddepression.nimh.nih.gov/infopage.asp?ID=1
The pharmaceutical industry’s latest antidepression drug marketing campaign is being launched with collaboration of the National Institute of Mental Health (NIMH)—
The Wall Street Journal and Bloomberg News report about a case involving Neuropsychopharmacology, the official journal of the American College of Neuropsychopharmacology (ACNP) that will likely go down in history as psychiatry’s Watergate.
Operating like thieves under the cover of darkness, prominent academic-based "authorities" in medical specialties have debased academic standards and sold their reputations for cash-
An OpEd in The New York Times (below) is trumpeting psychiatry’s latest “cure” for depression: it requires surgical implantation of electrodes in the brain, continued “maintenance” with powerful psychotropic drugs, and it costs $40,000.
A Come Back for Psychosurgery? Wed, 6 Aug 2003 The Los Angeles Times reports that experimental psychosurgery is once again on the rise – at Harvard’s Massachusetts General Hospital and Brown University. It is acknowledged that “Researchers still do not fully understand how the operations affect the brain, or why”……